Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 131

1.

Patients with advanced head and neck cancers have similar progression-free survival on phase I trials and their last food and drug administration-approved treatment.

Garrido-Laguna I, Janku F, Falchook GS, Fu S, Hong DS, Naing A, Aaron J, Wang X, Kies M, Kurzrock R.

Clin Cancer Res. 2010 Aug 1;16(15):4031-7. doi: 10.1158/1078-0432.CCR-10-0672. Epub 2010 Jun 4.

PMID:
20525754
[PubMed - indexed for MEDLINE]
Free Article
2.

Validation of the Royal Marsden Hospital prognostic score in patients treated in the Phase I Clinical Trials Program at the MD Anderson Cancer Center.

Garrido-Laguna I, Janku F, Vaklavas C, Falchook GS, Fu S, Hong DS, Naing A, Tsimberidou AM, Wen S, Kurzrock R.

Cancer. 2012 Mar 1;118(5):1422-8. doi: 10.1002/cncr.26413. Epub 2011 Aug 5.

PMID:
21823111
[PubMed - indexed for MEDLINE]
Free Article
3.

INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.

[No authors listed]

Drugs R D. 2007;8(3):176-87. Review.

PMID:
17472413
[PubMed - indexed for MEDLINE]
4.

Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer.

Argiris A, Stenson KM, Brockstein BE, Mittal BB, Pelzer H, Kies MS, Jayaram P, Portugal L, Wenig BL, Rosen FR, Haraf DJ, Vokes EE.

Head Neck. 2004 May;26(5):447-55.

PMID:
15122662
[PubMed - indexed for MEDLINE]
5.

Oblimersen: Augmerosen, BCL-2 antisense oligonucleotide - Genta, G 3139, GC 3139, oblimersen sodium.

[No authors listed]

Drugs R D. 2007;8(5):321-34. Review.

PMID:
17767397
[PubMed - indexed for MEDLINE]
6.

Randomized phase III trial of edatrexate versus methotrexate in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck: a European Organization for Research and Treatment of Cancer Head and Neck Cancer Cooperative Group study.

Schornagel JH, Verweij J, de Mulder PH, Cognetti F, Vermorken JB, Cappelaere P, Armand JP, Wildiers J, de Graeff A, Clavel M, et al.

J Clin Oncol. 1995 Jul;13(7):1649-55.

PMID:
7602354
[PubMed - indexed for MEDLINE]
7.

Therapeutic decision making in stages III and IV head and neck squamous cell carcinoma.

Gleich LL, Collins CM, Gartside PS, Gluckman JL, Barrett WL, Wilson KM, Biddinger PW, Redmond KP.

Arch Otolaryngol Head Neck Surg. 2003 Jan;129(1):26-35.

PMID:
12525191
[PubMed - indexed for MEDLINE]
8.

Phase 2 study of intratumoral cisplatin and epinephrine treatment for locally recurrent head and neck tumors.

Duvillard C, Romanet P, Cosmidis A, Beaudouin N, Chauffert B.

Ann Otol Rhinol Laryngol. 2004 Mar;113(3 Pt 1):229-33.

PMID:
15053208
[PubMed - indexed for MEDLINE]
9.

Prognostic factors and long-term survivorship in patients with recurrent or metastatic carcinoma of the head and neck.

Argiris A, Li Y, Forastiere A.

Cancer. 2004 Nov 15;101(10):2222-9.

PMID:
15452834
[PubMed - indexed for MEDLINE]
Free Article
10.

Predictors of response and survival after concurrent chemotherapy and radiation for locally advanced squamous cell carcinomas of the head and neck.

Suntharalingam M, Haas ML, Van Echo DA, Haddad R, Jacobs MC, Levy S, Gray WC, Ord RA, Conley BA.

Cancer. 2001 Feb 1;91(3):548-54.

PMID:
11169937
[PubMed - indexed for MEDLINE]
11.

Bleomycin--electrical pulse delivery: electroporation therapy-bleomycin--Genetronics; MedPulser-bleomycin--Genetronics.

[No authors listed]

Drugs R D. 2004;5(5):293-6.

PMID:
15357628
[PubMed - indexed for MEDLINE]
12.

Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group.

Gibson MK, Li Y, Murphy B, Hussain MH, DeConti RC, Ensley J, Forastiere AA; Eastern Cooperative Oncology Group.

J Clin Oncol. 2005 May 20;23(15):3562-7.

PMID:
15908667
[PubMed - indexed for MEDLINE]
Free Article
13.

Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.

Shin DM, Glisson BS, Khuri FR, Hong WK, Lippman SM.

Semin Oncol. 1998 Apr;25(2 Suppl 4):40-4; discussion 45-8.

PMID:
9578061
[PubMed - indexed for MEDLINE]
14.

Sorafenib for the treatment of advanced renal cell carcinoma.

Kane RC, Farrell AT, Saber H, Tang S, Williams G, Jee JM, Liang C, Booth B, Chidambaram N, Morse D, Sridhara R, Garvey P, Justice R, Pazdur R.

Clin Cancer Res. 2006 Dec 15;12(24):7271-8. Review.

PMID:
17189398
[PubMed - indexed for MEDLINE]
Free Article
15.

Hemoglobin as an independent prognostic factor in the radiotherapy of head and neck tumors.

Schäfer U, Micke O, Müller SB, Schüller P, Willich N.

Strahlenther Onkol. 2003 Aug;179(8):527-34.

PMID:
14509951
[PubMed - indexed for MEDLINE]
16.

Outcome of elderly patients with recurrent or metastatic head and neck cancer treated with cisplatin-based chemotherapy.

Argiris A, Li Y, Murphy BA, Langer CJ, Forastiere AA.

J Clin Oncol. 2004 Jan 15;22(2):262-8.

PMID:
14722034
[PubMed - indexed for MEDLINE]
Free Article
17.

Phase II trial of the histone deacetylase inhibitor vorinostat (Zolinza, suberoylanilide hydroxamic acid, SAHA) in patients with recurrent and/or metastatic head and neck cancer.

Blumenschein GR Jr, Kies MS, Papadimitrakopoulou VA, Lu C, Kumar AJ, Ricker JL, Chiao JH, Chen C, Frankel SR.

Invest New Drugs. 2008 Feb;26(1):81-7. Epub 2007 Oct 25.

PMID:
17960324
[PubMed - indexed for MEDLINE]
18.

Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.

Okuno SH, Mailliard JA, Suman VJ, Edmonson JH, Creagan ET, Nair S, Levitt R, Kugler JW.

Cancer. 2002 Apr 15;94(8):2224-31.

PMID:
12001121
[PubMed - indexed for MEDLINE]
19.

Recurrent and/or metastatic head and neck squamous cell carcinoma: a clinical, univariate and multivariate analysis of response and survival with cisplatin-based chemotherapy.

Recondo G, Armand JP, Tellez-Bernal E, Domenge C, Belehradek M, De Vathaire F, Wibault P, Richard JM, Cvitkovic E.

Laryngoscope. 1991 May;101(5):494-501.

PMID:
1709437
[PubMed - indexed for MEDLINE]
20.

Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.

Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, Forastiere A, Gillison ML.

J Natl Cancer Inst. 2008 Feb 20;100(4):261-9. doi: 10.1093/jnci/djn011. Epub 2008 Feb 12.

PMID:
18270337
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk